PLK1 and urinary bladder carcinoma: Studies have shown that PLK1 is overexpressed in colorectal cancer [36], pancreatic cancer [37], gastric cancer [38], prostate cancer [39], thyroid cancer [40], bladder cancer, and other tumors [41], and the high expression of PLK1 indicates poor clinical prognosis.